{
  "id": 727247,
  "title": "KPJ Healthcare Q2 profit seen rising to RM92mil",
  "url": "https://urgent.news/2026/08/13/kpj-healthcare-q2-profit-seen-rising-to-rm92mil",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-13T03:49:09.000Z",
  "source": {
    "name": "New Straits Times",
    "slug": "new-straits-times",
    "url": "https://www.nst.com.my/business/corporate/2026/08/1510229/kpj-healthcare-q2-profit-seen-rising-rm92mil"
  },
  "original_language": "en",
  "account": "KPJ Healthcare Bhd anticipates a higher second quarter net profit of around RM92 million for Q2 2026, according to RHB Research. The firm attributes this increase to growing patient volumes, enhanced revenue intensity, and restored margins. Consequently, first-half 2026 earnings are projected to hit 40% and 41% of both internal and analyst estimates. The fourth quarter is expected to outperform due to KPJ's domestic-focused portfolio and lower medical tourism exposure. RHB Research predicts a 4% YoY rise in revenue intensity and a 1% YoY increase in inpatient admissions, with EBITDA margin conservatively estimated at 22.5%. The sequential margin improvement is anticipated to stem from elevated bed occupancy post-festive season and investments in IT and digital infrastructure. RHB Research assumes a 32% effective tax rate, closer to the 28-31% range management has indicated. The firm recently inaugurated its third Center of Excellence (COE) at KPJ Penang Specialist (Orthopaedic & Rheumatology), complementing the Heart & Lung COE at KPJ Johor Specialist Hospital and Neuroscience & Stroke COE at Damansara Specialist Hospital 2. These additions aim to bolster clinical capacities and augment revenue intensity over time by harnessing secondary hospital networks and primary care alliances for referral growth. RHB maintains a Buy rating on KPJ Healthcare with a RM3.77 target price.",
  "summary": "KUALA LUMPUR: KPJ Healthcare Bhd is expected to report a sequentially stronger second quarter 2026 (Q2 FY26) net profit of about RM92 million, said RHB Research.",
  "key_points": [
    "KPJ Healthcare anticipates RM92 million Q2 2026 profit",
    "First-half 2026 earnings to reach 40%-41% of estimates",
    "Q4 expected to outperform due to domestic focus"
  ],
  "editors_take": "The expected rise in KPJ Healthcare's Q2 profit reflects growing patient volumes, revenue intensity, and restored margins, bolstering RHB Research's Buy rating and RM3.77 target price for the company.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}